How to achieve international action on falsified and substandard medicines

2012147 citationsJournal Articlebronze Open Access

Authors

Amir Attaran · University of Ottawa

D. Barry · Partners In Health

Shamnad Basheer · West Bengal National University of Juridical Sciences

Roger Bate · American Enterprise Institute

David Benton · International Council of Nurses

James Chauvin · World Federation of Public Health Associations

L. Garrett

Abstract

Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. <b>Amir Attaran and colleagues</b> propose a global treaty to overcome the problems

Topics & Keywords

Pharmaceutical Quality and Counterfeiting Pharmaceutical Economics and Policy Intellectual Property and Patents

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: BMJ

Volume 345, Issue nov13 22, pp. e7381-e7381

DOI: 10.1136/bmj.e7381

Field-Weighted Citation Impact: 14.14